Skip to content
Trial Agents

Rebar Interactive

Rebar Interactive is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

7distinct trials
4recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 7 of 7 trials · Latest update first

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib following Definitive Locoregional Treatment in Participants with Stage IB-IIIA RET fusion-Positive NSCLC

Sponsor Eli Lilly & Co.

Start (EU)
Latest update
Estimated end

J2G-MC-JZJB: A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients with Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)

Sponsor Eli Lilly & Co.

Start (EU)
Latest update
Estimated end

J2G-MC-JZJC: LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Sponsor Eli Lilly & Co.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Rebar Interactive?

The 2026-10-09 snapshot links Rebar Interactive to 7 distinct CTIS trials. Recorded services include Patient Referral, Recruitment, Screening, and/or Retention, Patient Screening, Recruitment, and /0r Retention, Patient Screening, Recruitment, and/or Retention, Patient Screening, Recruitment, and/or Retention Clinical Trial Recruitment vendor system for processing investigator and potential trial participant PI. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Rebar Interactive?

The most frequently recorded therapeutic areas are Solid Tumor Oncology, Endocrinology, Respiratory. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Rebar Interactive conducted?

The linked trials record locations in 14 countries, including Spain, Italy, Netherlands, France, Belgium. These are trial locations, not confirmed office locations or countries where Rebar Interactive delivered services.

What can this page tell me about Rebar Interactive's trial experience?

Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Rebar Interactive. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Rebar Interactive LLC

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.